NDC 59368-405-02 - Eprontia
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59368-405
- Requested NDC
- 59368-405-02
- Package NDCs from labels
- 59368-405-02, 59368-405-01
- Manufacturer
- Praxis, LLC
- Effective date
- 2023-01-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Eprontia - Praxis, LLC | Praxis, LLC | 2023-01-01 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Leader Eye Drops Redness Relief | GLYCERIN, NAPHAZOLINE HYDROCHLORIDE | Cardinal Health | aee4bbe2-4f11-4c54-be8b-df48b3ba4f3a | 2026-09-09 | Warnings | PDC6A3C0OX |
| Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Rite Aid Corporation | 407c78ca-6fee-4ed6-b61b-711ec049c86e | 2026-09-09 | Warnings | PDC6A3C0OX |
| Clear Eyes Nighttime | GLYCERIN | Prestige Brands Holdings, Inc. | af75e2f7-81dd-43e0-a390-b52bbfbebf62 | 2026-09-08 | Warnings | PDC6A3C0OX |
| Topiramate | TOPIRAMATE | REMEDYREPACK INC. | 3f99b26b-79b9-4efb-aa2c-2868e1e126c8 | 2026-09-04 | Warnings, Adverse reactions | 0H73WJJ391 |
| Hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | CVS Pharmacy | 3167c918-a7d3-46a1-a85b-64f9c22916f2 | 2026-09-04 | Warnings | PDC6A3C0OX |
| QUDEXY XR | TOPIRAMATE | Upsher-Smith Laboratories, LLC | 46f54677-3a22-4c38-9b92-923020164e15 | 2026-09-03 | Warnings, Adverse reactions | 0H73WJJ391 |
| topiramate | TOPIRAMATE | REMEDYREPACK INC. | 0c0a6774-e234-47a5-866e-462cfd99744c | 2026-09-01 | Warnings, Adverse reactions | 0H73WJJ391 |
| topiramate | TOPIRAMATE | Coupler LLC | 59f39dea-f29b-d6c6-e063-6294a90a5b74 | 2026-08-26 | Warnings, Adverse reactions | 0H73WJJ391 |
| Leader Dry Eye Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | CARDINAL HEALTH 110, LLC. DBA LEADER | 2ded4bda-b3c3-4521-8701-5c8446fd148b | 2026-08-17 | Warnings | PDC6A3C0OX |
| BM BM164 DROPS | ARUM TRYPH, CAUSTICUM, BALSAMUM PERU, HELONIAS DIO, ACID PHOS, GLYCERINUM, EQUISETUM | BM Private Limited | 5902770f-eb01-d099-e063-6394a90ad3eb | 2026-08-14 | Warnings | PDC6A3C0OX |
| CVS Glycerin | GLYCERIN SUPPOISITORY | CVS Pharmacy, Inc | ca6d13db-60e8-4fcc-b7b3-3eb280b8c435 | 2026-08-04 | Warnings | PDC6A3C0OX |
| topiramate | TOPIRAMATE | Coupler LLC | 5826cb22-3559-171b-e063-6394a90ad594 | 2026-08-03 | Warnings, Adverse reactions | 0H73WJJ391 |
| Topiramate | TOPIRAMATE | REMEDYREPACK INC. | c90d81a9-a87b-48b0-8cf1-172b82e30127 | 2026-07-31 | Warnings, Adverse reactions | 0H73WJJ391 |
| Topiramate | TOPIRAMATE | PD-Rx Pharmaceuticals, Inc. | 4833f2e8-16b7-406f-937a-55bc978bf92c | 2026-07-29 | Warnings, Adverse reactions | 0H73WJJ391 |
| Topwin Speedy Enema | GLYCERIN | Health Chemical Pharmaceutical Co., Ltd | 3ba8c3d2-1780-42e1-bec5-8f98771d475e | 2026-07-27 | Warnings | PDC6A3C0OX |
| Droptics Dry Eye Relief | CARBOXYMETHYLCELLULOSE SODIUM,GLYCERIN,POLYSORBATE 80 | Droptics LLC | 29d7614b-f4b7-48e2-97c5-d1bff27731d2 | 2026-07-22 | Warnings | PDC6A3C0OX |
| Topiramate | TOPIRAMATE | REMEDYREPACK INC. | 44095c2b-2e90-45d2-ab45-d0961c41550d | 2026-07-20 | Warnings, Adverse reactions | 0H73WJJ391 |
| topiramate | TOPIRAMATE | REMEDYREPACK INC. | 7e0834ee-920b-496f-954d-f9d81c3ba2d6 | 2026-07-17 | Warnings, Adverse reactions | 0H73WJJ391 |
| Topiramate | TOPIRAMATE | REMEDYREPACK INC. | b71c09c5-43dd-4d98-9ab6-0b0c99908cac | 2026-07-09 | Warnings, Adverse reactions | 0H73WJJ391 |
| Topiramate | TOPIRAMATE | REMEDYREPACK INC. | f8aaf403-0e15-4bbb-b88b-253d93439688 | 2026-07-09 | Warnings, Adverse reactions | 0H73WJJ391 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.